Literature DB >> 26253489

Recent advances in isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids of marine origin.

Bhavitavya Nijampatnam1, Shilpa Dutta1, Sadanandan E Velu2.   

Abstract

The ocean continues to provide a plethora of unique scaffolds capable of remarkable biological applications. A large number of pyrroloiminoquinone alkaloids, including discorhabdins, epinardins, batzellines, makaluvamines, and veiutamine, have been isolated from various marine organisms. A class of pyrroloiminoquinone-related alkaloids, known as bispyrroloquinones, is the focus of this review article. This family of marine alkaloids, which contain an aryl substituted bispyrroloquinone ring system, includes three subclasses of alkaloids namely, wakayin, tsitsikammamines A-B, and zyzzyanones A-D. Both wakayin and the tsitsikammamines contain a tetracyclic fused bispyrroloiminoquinone ring system, while zyzzyanones contain a fused tricyclic bispyrroloquinone ring system. The unique chemical structures of these marine natural products and their diverse biological properties, including antifungal and antimicrobial activity, as well as the potent, albeit generally nonspecific and universal cytotoxicities, have attracted great interest of synthetic chemists over the past three decades. Tsitsikammamines, wakayin, and several of their analogs show inhibition of topoisomerases. One additional possible mechanism of anticancer activity of tsitsikammamines analogs that has been discovered recently is through the inhibition of indoleamine 2, 3-dioxygenase, an enzyme involved in tumoral immune resistance. This review discusses the isolation, synthesis, and evaluation of bioactivities of bispyrroloquinone alkaloids and their analogs.
Copyright © 2015 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticancer; Antimicrobial; Bispyrroloquinones; Topoisomerase; Tsitsikammamines; Wakayin; Zyzzyanones

Mesh:

Substances:

Year:  2015        PMID: 26253489      PMCID: PMC4710477          DOI: 10.1016/S1875-5364(15)30052-2

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  57 in total

Review 1.  Marine natural products as anticancer drugs.

Authors:  T Luke Simmons; Eric Andrianasolo; Kerry McPhail; Patricia Flatt; William H Gerwick
Journal:  Mol Cancer Ther       Date:  2005-02       Impact factor: 6.261

Review 2.  Marine natural products.

Authors:  John W Blunt; Brent R Copp; Murray H G Munro; Peter T Northcote; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2006-01-09       Impact factor: 13.423

3.  Synthesis and in vitro evaluation of imidazole-based wakayin analogues.

Authors:  Hung Hoang; Xiaofen Huang; Edward B Skibo
Journal:  Org Biomol Chem       Date:  2008-07-16       Impact factor: 3.876

4.  Makaluvamine P, a new cytotoxic pyrroloiminoquinone from Zyzzya cf. fuliginosa.

Authors:  A Casapullo; A Cutignano; I Bruno; G Bifulco; C Debitus; L Gomez-Paloma; R Riccio
Journal:  J Nat Prod       Date:  2001-10       Impact factor: 4.050

5.  New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.

Authors:  Jin-Feng Hu; John A Schetz; Michelle Kelly; Jiang-Nan Peng; Kenny K H Ang; Horst Flotow; Chung Yan Leong; Siew Bee Ng; Antony D Buss; Scott P Wilkins; Mark T Hamann
Journal:  J Nat Prod       Date:  2002-04       Impact factor: 4.050

6.  Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges.

Authors:  Edith M Antunes; Denzil R Beukes; Michelle Kelly; Toufiek Samaai; Louis R Barrows; Kathryn M Marshall; Catherine Sincich; Michael T Davies-Coleman
Journal:  J Nat Prod       Date:  2004-08       Impact factor: 4.050

7.  AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex.

Authors:  Kathryn M Marshall; Joseph A Holden; Avi Koller; Yoel Kashman; Brent R Copp; Louis R Barrows
Journal:  Anticancer Drugs       Date:  2004-10       Impact factor: 2.248

8.  Calothrixins, a new class of human DNA topoisomerase I poisons.

Authors:  Qasim A Khan; Jun Lu; Sidney M Hecht
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

Review 9.  Trabectedin in soft tissue sarcomas.

Authors:  Bradley J Petek; Elizabeth T Loggers; Seth M Pollack; Robin L Jones
Journal:  Mar Drugs       Date:  2015-02-12       Impact factor: 5.118

Review 10.  Anti-obesity activity of the marine carotenoid fucoxanthin.

Authors:  Maria Alessandra Gammone; Nicolantonio D'Orazio
Journal:  Mar Drugs       Date:  2015-04-13       Impact factor: 5.118

View more
  3 in total

1.  Design, Synthesis, and Apoptosis-Promoting Effect Evaluation of Rhopaladins' Analog 4-Arylidene-5-Oxopyrrolidine Derivatives.

Authors:  Jun Zhu; Ling-Qi Kong; Qin-Hua Chen; Bin Li; Lun Wu; Feng-Ying Ran; Li-Na Ke; Xiao-Hua Zeng; Hong-Mei Wang
Journal:  Front Chem       Date:  2022-05-18       Impact factor: 5.545

2.  Green synthesis, structure optimization and biological evalution of Rhopaladins' analog 2-styryl-5-oxopyrrolidine-2- carboxamide RPDPRH on CaSki cells.

Authors:  Li-Na Ke; Ling-Qi Kong; Xiu-Lian Zhu; Feng-Xu Wu; Qin-Hua Chen; Bin Li; Yun Dong; Hong-Mei Wang; Xiao-Hua Zeng
Journal:  Front Chem       Date:  2022-08-30       Impact factor: 5.545

Review 3.  Polycyclic Guanidine Alkaloids from Poecilosclerida Marine Sponges.

Authors:  Estelle Sfecci; Thierry Lacour; Philippe Amade; Mohamed Mehiri
Journal:  Mar Drugs       Date:  2016-04-09       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.